Abstract: A reconfigurable chair includes features that open up new sitting and resting positions for the user. The chair includes rotatable lateral side rests and a tilt adjustable back rest which when reconfigured, provide auxiliary resting platforms to support the body in different sitting and resting positions. The backrest may include a rotatable feature so that the backrest may be moved from an upright position to a flat position adding another level of support. A height adjustment mechanism may adjust the height of the backrest to add to the reconfigurability of the chair. Some embodiments include one or more gas pistons providing user-controlled adjustment of elements into any of an infinite number of user-controlled positions.

Abstract: A reconfigurable chair includes features that open up new sitting and resting positions for the user. The chair includes rotatable lateral side rests and a tilt adjustable back rest which when reconfigured, provide auxiliary resting platforms to support the body in different sitting and resting positions. The backrest may include a rotatable feature so that the backrest may be moved from an upright position to a flat position adding another level of support. A height adjustment mechanism may adjust the height of the backrest to add to the reconfigurability of the chair.

Abstract: Provided are compositions and methods for activating latent Human Immunodeciency Virus (HIV). The compositions and methods may utilize a recombinant peptide that has a DNA-binding zinc finger domain specific to the HIV LTR sequence. The recombinant peptide may also have a transcription factor (e.g. a transcription activator) that is conjuated to the zinc finger domain. Also provided are methods of treating HIV in a subject in need of the treatment. The method may involve activation of latent HIV in cells of the subject and selectively removing such cells from the subject, providing complete and effective treatment of HIV.

Abstract: Disclosed are small molecule inhibitors of SLC15A4, and methods of using them to treat pDC-mediated diseases and conditions.

Abstract: Provided are compositions and methods for activating latent Human Immunodeficiency Virus (HIV). The compositions and methods may utilize a recombinant peptide that has a DNA binding zinc finger domain specific to the HIV long terminal repeat (LTR) sequence. The recombinant peptide may also have a transcription factor (e.g. a transcription activator) that is conjugated to the zinc finger domain. Also provided are methods of treating HIV in a subject in need of the treatment. The method may involve activation of latent HIV in cells of the subject and selectively removing such cells from the subject, providing complete and effective treatment of HIV.

Abstract: A reconfigurable chair includes features that open up new sitting and resting positions for the user. The chair includes rotatable lateral side rests and a tilt adjustable back rest which when reconfigured, provide auxiliary resting platforms to support the body in different sitting and resting positions. The backrest may include a rotatable feature so that the backrest may be moved from an upright position to a flat position adding another level of support. A height adjustment mechanism may adjust the height of the backrest to add to the reconfigurability of the chair.

Abstract: Provided are compositions and methods for activating latent Human Immunodeficiency Virus (HIV). The compositions and methods may utilize a recombinant peptide that has a DNA binding zinc finger domain specific to the HIV long terminal repeat (LTR) sequence. The recombinant peptide may also have a transcription factor (e.g. a transcription activator) that is conjugated to the zinc finger domain. Also provided are methods of treating HIV in a subject in need of the treatment. The method may involve activation of latent HIV in cells of the subject and selectively removing such cells from the subject, providing complete and effective treatment of HIV.